Blockchain Registration Transaction Record

Oragenics to Showcase Concussion Treatment at Major Biotech Events

Oragenics to present ONP-002, a novel concussion treatment, at 2025 BIO International Convention and National Neurotrauma Society Symposium, showcasing advancements in neurology.

This news is significant as it highlights Oragenics' commitment to advancing treatment options for concussions and other neurological conditions. With concussions being a major concern in sports and everyday accidents, the development of effective treatments like ONP-002 could have a profound impact on patient recovery and quality of life. Additionally, Oragenics' participation in these prestigious events underscores the potential of their research to attract attention and investment from the global biotech community, accelerating the path to market for their innovative therapies.